The u. S. Food & drug administration, (FDA) office of acquisition and grants services (oags) has a requirement to procure PBL assay sciences verikine-HS human IFN beta serum elisa kits.

Ended Purchase Order Awarded

Contract number
75F40121P00192
Awardee
Awarding agency
Obligated
$38,895

Award facts

Opportunity
  • RFQFDA20211242653 Solicitation number
Contract value 100% obligated
$38,895.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Piscataway, NJ 08854, USA

Award details come from SAM.gov/FPDS.

Quick answers

Who was awarded contract 75F40121P00192?

75F40121P00192 was awarded to Pestka Biomedical Laboratories, Inc. by Food and Drug Administration (Department of Health and Human Services) on June 16, 2021.

How much is contract 75F40121P00192 worth?

The government has obligated $38,895 on 75F40121P00192.

Was contract 75F40121P00192 competed?

The extent of competition for 75F40121P00192 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award